Cerevel Therapeutics Holdings Inc. (CERE) NASDAQ

$42.10 (0.11) (-0.26%)

Market Cap: $7.66B

As of 04/22/24 04:00 PM EDT. Market closed.

Cerevel Therapeutics Holdings Inc. (CERE)
NASDAQ

$42.10
(0.11) (-0.26%)

Market Cap: $7.66B

As of 04/22/24 04:00 PM EDT. Market closed.

Add to Portfolio

cerevel therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (cns). the company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of cns disorders, including parkinson’s, alzheimer’s, epilepsy, ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Anthony Coles Jr.
Full Time Employees
275
URL
Address
222 Jacobs Street, Suite 200, MA, Cambridge, 02141.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Anthony Coles Jr.
Full Time Employees
275
Address
222 Jacobs Street, Suite 200, MA, Cambridge, 02141.
PRICE CHART FOR CEREVEL THERAPEUTICS HOLDINGS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$42.24
Previous Close
$42.21
Days Range
$42 - $42.23
52 week range
$19.59 - $43.59
Volume
701,473
Avg. Volume (30 days)
1,182,937
Market Cap
$7.66B
Dividend Yield
-
P/E
-
Shares Outstanding
181,576,482
Open
$42.24
Previous Close
$42.21
Days Range
$42 - $42.23
52 week range
$19.59 - $43.59
Volume
701,473
Avg. Volume (30 days)
1,182,937
Market Cap
$7.66B
Dividend Yield
-
P/E
-
Shares Outstanding
181,576,482
FINANCIAL STATEMENTS FOR CEREVEL THERAPEUTICS HOLDINGS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CEREVEL THERAPEUTICS HOLDINGS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
COLES N ANTHONYDirectorApr 01, 2024 Option Exercise$3.5050,000175,00065,638Apr 03, 2024, 04:15 PM
COLES N ANTHONYDirectorApr 01, 2024 Sale$42.3350,0002,116,64015,638Apr 03, 2024, 04:15 PM
COLES N ANTHONYDirectorMar 04, 2024 Option Exercise$3.5050,000175,00065,638Mar 06, 2024, 04:15 PM
COLES N ANTHONYDirectorMar 04, 2024 Sale$41.0150,0002,050,55015,638Mar 06, 2024, 04:15 PM
COLES N ANTHONYDirectorFeb 29, 2024 Option Exercise$3.5050,000175,00065,638Mar 04, 2024, 05:49 PM
COLES N ANTHONYDirectorFeb 29, 2024 Sale$41.1650,0002,057,89015,638Mar 04, 2024, 05:49 PM
Renger JohnChief Scientific OfficerFeb 07, 2024 Sale$41.542,16189,7776,370Feb 08, 2024, 07:19 PM
COLES N ANTHONYDirectorFeb 07, 2024 Sale$41.542,506104,11015,638Feb 08, 2024, 07:14 PM
Tregoning KathleenSee RemarksDec 26, 2023 Option Exercise$10.053,15031,65810,666Dec 28, 2023, 04:15 PM
Sanchez RamiroChief Medical OfficerDec 26, 2023 Option Exercise$3.5010,00035,00024,673Dec 28, 2023, 04:15 PM
Sanchez RamiroChief Medical OfficerDec 26, 2023 Sale$42.4710,000424,70014,673Dec 28, 2023, 04:15 PM
DiPietro KennethChief Human Resources OfficerDec 22, 2023 Option Exercise$3.508,00028,00032,663Dec 27, 2023, 04:15 PM
DiPietro KennethChief Human Resources OfficerDec 22, 2023 Sale$41.458,000331,60824,663Dec 27, 2023, 04:15 PM
Bodenrader MarkSee RemarksDec 20, 2023 Sale$41.427,889326,78817,724Dec 21, 2023, 08:27 PM
DiPietro KennethChief Human Resources OfficerDec 20, 2023 Sale$41.426,256259,14424,663Dec 21, 2023, 08:24 PM
Akamine ScottChief Legal OfficerDec 20, 2023 Sale$41.427,072292,9457,237Dec 21, 2023, 08:21 PM
Sanchez RamiroChief Medical OfficerDec 20, 2023 Sale$41.4210,152420,52814,673Dec 21, 2023, 08:14 PM
ALTSCHULLER SusanChief Financial OfficerDec 20, 2023 Sale$41.4213,808571,97216,913Dec 21, 2023, 08:12 PM
Tregoning KathleenSee RemarksDec 20, 2023 Sale$41.426,288260,4697,516Dec 21, 2023, 08:10 PM
Sanchez RamiroChief Medical OfficerDec 15, 2023 Option Exercise$9.887,50074,1007,500Dec 19, 2023, 04:15 PM
Sanchez RamiroChief Medical OfficerDec 15, 2023 Sale$41.397,500310,3930Dec 19, 2023, 04:15 PM
Sanchez RamiroChief Medical OfficerDec 07, 2023 Option Exercise$3.5010,00035,00010,000Dec 11, 2023, 04:17 PM
Sanchez RamiroChief Medical OfficerDec 07, 2023 Sale$41.3710,000413,7000Dec 11, 2023, 04:17 PM
Akamine ScottChief Legal OfficerDec 07, 2023 Option Exercise$13.1710,000131,70010,513Dec 07, 2023, 07:45 PM
Akamine ScottChief Legal OfficerDec 05, 2023 Option Exercise$13.177,50098,7758,013Dec 07, 2023, 07:45 PM
Akamine ScottChief Legal OfficerDec 07, 2023 Sale$41.3710,000413,700513Dec 07, 2023, 07:45 PM
Akamine ScottChief Legal OfficerDec 05, 2023 Sale$35.007,500262,500513Dec 07, 2023, 07:45 PM
COLES N ANTHONYDirectorNov 14, 2023 Option Exercise$3.5022,82479,88425,528Nov 16, 2023, 04:15 PM
COLES N ANTHONYDirectorNov 14, 2023 Sale$25.1322,824573,4552,704Nov 16, 2023, 04:15 PM
COLES N ANTHONYDirectorNov 08, 2023 Option Exercise$3.501003502,804Nov 09, 2023, 05:03 PM
COLES N ANTHONYDirectorNov 07, 2023 Option Exercise$3.5027,07694,76629,780Nov 09, 2023, 05:03 PM
COLES N ANTHONYDirectorNov 08, 2023 Sale$25.161002,5162,704Nov 09, 2023, 05:03 PM
COLES N ANTHONYDirectorNov 07, 2023 Sale$25.0227,076677,5552,704Nov 09, 2023, 05:03 PM
COLES N ANTHONYDirectorNov 02, 2023 Option Exercise$3.5038,599135,09741,303Nov 06, 2023, 05:12 PM
COLES N ANTHONYDirectorNov 03, 2023 Option Exercise$3.5061,401214,90464,105Nov 06, 2023, 05:12 PM
COLES N ANTHONYDirectorNov 03, 2023 Sale$25.4361,4011,561,4582,704Nov 06, 2023, 05:12 PM
COLES N ANTHONYDirectorNov 02, 2023 Sale$25.1938,599972,2392,704Nov 06, 2023, 05:12 PM
PATRICK DEVAL LDirectorNov 01, 2023 Option Exercise$12.6230,130380,24133,412Nov 03, 2023, 04:15 PM
PATRICK DEVAL LDirectorNov 01, 2023 Sale$25.0030,130753,2503,282Nov 03, 2023, 04:15 PM
Gordon Christopher RDirectorOct 16, 2023 Buy$22.815,480,052124,999,98365,679,781Oct 18, 2023, 04:30 PM
Koppel AdamDirectorOct 16, 2023 Buy$22.815,480,052124,999,98365,679,781Oct 18, 2023, 04:30 PM
BAIN CAPITAL INVESTORS LLC10% OwnerOct 16, 2023 Buy$22.815,480,052124,999,98365,679,781Oct 18, 2023, 04:30 PM
PERCEPTIVE ADVISORS LLCDirectorOct 16, 2023 Buy$22.81876,80819,999,99010,794,876Oct 17, 2023, 04:53 PM
COLES N ANTHONYDirectorSep 07, 2023 Option Exercise$3.5050,000175,00052,704Sep 08, 2023, 04:35 PM
COLES N ANTHONYDirectorSep 07, 2023 Sale$24.0750,0001,203,4152,704Sep 08, 2023, 04:35 PM
Renaud Ronald C JRPresident & CEOAug 03, 2023 Buy$23.9683,8572,008,81183,857Aug 07, 2023, 05:13 PM
Burgess Paul D.See RemarksAug 04, 2023 Buy$22.9321,880501,79421,880Aug 07, 2023, 05:11 PM
COLES N ANTHONYDirectorJul 11, 2023 Option Exercise$3.5050,000175,00052,704Jul 13, 2023, 05:41 PM
COLES N ANTHONYDirectorJul 11, 2023 Sale$30.0350,0001,501,3402,704Jul 13, 2023, 05:41 PM
DEKKERS MARIJN EDirectorJun 15, 2023 Sale$34.43200,0006,886,000402,326Jun 20, 2023, 04:56 PM
COLES N ANTHONYCEO and ChairpersonJun 01, 2023 Option Exercise$3.5050,000175,00052,704Jun 05, 2023, 08:12 PM
COLES N ANTHONYCEO and ChairpersonJun 01, 2023 Sale$32.6050,0001,630,0702,704Jun 05, 2023, 08:12 PM
Bodenrader MarkSee RemarksJun 02, 2023 Sale$32.951,89562,4405,522Jun 05, 2023, 08:07 PM
COLES N ANTHONYCEO and ChairpersonMay 04, 2023 Option Exercise$3.5050,000175,00052,704May 08, 2023, 04:24 PM
COLES N ANTHONYCEO and ChairpersonMay 04, 2023 Sale$31.4750,0001,573,43415,136May 08, 2023, 04:24 PM
COLES N ANTHONYCEO and ChairpersonApr 11, 2023 Option Exercise$3.5050,000175,00052,704Apr 13, 2023, 04:48 PM
COLES N ANTHONYCEO and ChairpersonApr 11, 2023 Sale$25.0650,0001,253,1302,704Apr 13, 2023, 04:48 PM
COLES N ANTHONYCEO and ChairpersonMar 03, 2023 Option Exercise$3.503,00010,5005,704Mar 06, 2023, 04:15 PM
COLES N ANTHONYCEO and ChairpersonMar 02, 2023 Option Exercise$3.5047,000164,50049,704Mar 06, 2023, 04:15 PM
COLES N ANTHONYCEO and ChairpersonMar 03, 2023 Sale$27.193,00081,5702,704Mar 06, 2023, 04:15 PM
COLES N ANTHONYCEO and ChairpersonMar 02, 2023 Sale$27.1147,0001,274,3772,704Mar 06, 2023, 04:15 PM
COLES N ANTHONYCEO and ChairpersonFeb 07, 2023 Option Exercise$3.5050,000175,00052,704Feb 08, 2023, 08:27 PM
COLES N ANTHONYCEO and ChairpersonFeb 07, 2023 Sale$33.1350,0001,656,40110,646Feb 08, 2023, 08:27 PM
COLES N ANTHONYCEO and ChairpersonJan 05, 2023 Option Exercise$3.5050,000175,00052,704Jan 06, 2023, 05:04 PM
COLES N ANTHONYCEO and ChairpersonJan 05, 2023 Sale$29.9450,0001,496,8713,204Jan 06, 2023, 05:04 PM
COLES N ANTHONYCEO and ChairpersonDec 09, 2022 Option Exercise$3.5050,000175,00052,704Dec 13, 2022, 04:44 PM
COLES N ANTHONYCEO and ChairpersonDec 09, 2022 Sale$26.6750,0001,333,3007,849Dec 13, 2022, 04:44 PM
Renger JohnChief Scientific OfficerNov 01, 2022 Option Exercise$7.5625,000189,07827,704Nov 03, 2022, 04:28 PM
Renger JohnChief Scientific OfficerNov 01, 2022 Sale$30.0025,000750,0052,704Nov 03, 2022, 04:28 PM
Renger JohnChief Scientific OfficerOct 04, 2022 Option Exercise$7.5625,000189,07827,704Oct 06, 2022, 04:59 PM
Renger JohnChief Scientific OfficerOct 04, 2022 Sale$30.0025,000750,0002,704Oct 06, 2022, 04:59 PM
PATRICK DEVAL LDirectorSep 12, 2022 Option Exercise$12.6247,705602,03747,705Sep 14, 2022, 05:10 PM
PATRICK DEVAL LDirectorSep 12, 2022 Sale$30.7847,7051,468,4220Sep 14, 2022, 05:10 PM
Ceesay AbrahamPresidentSep 08, 2022 Option Exercise$13.1719,210252,99619,210Sep 12, 2022, 04:24 PM
Ceesay AbrahamPresidentSep 08, 2022 Sale$32.5019,210624,3250Sep 12, 2022, 04:24 PM
Ceesay AbrahamPresidentAug 22, 2022 Option Exercise$13.179,605126,4989,605Aug 24, 2022, 04:05 PM
Ceesay AbrahamPresidentAug 22, 2022 Sale$32.509,605312,1630Aug 24, 2022, 04:05 PM
PERCEPTIVE ADVISORS LLCDirectorAug 16, 2022 Buy$35.001,425,00049,875,0006,511,727Aug 18, 2022, 05:10 PM
Ceesay AbrahamPresidentAug 15, 2022 Option Exercise$13.179,606126,5119,606Aug 17, 2022, 04:15 PM
Ceesay AbrahamPresidentAug 15, 2022 Sale$34.129,606327,7570Aug 17, 2022, 04:15 PM
Renger JohnChief Scientific OfficerAug 10, 2022 Option Exercise$6.6355,000364,54957,704Aug 12, 2022, 04:15 PM
Renger JohnChief Scientific OfficerAug 10, 2022 Sale$40.5055,0002,227,62421,563Aug 12, 2022, 04:15 PM
Renger JohnChief Scientific OfficerAug 08, 2022 Option Exercise$3.5010,00035,00012,704Aug 09, 2022, 09:23 PM
Renger JohnChief Scientific OfficerAug 05, 2022 Option Exercise$3.5020,00070,00022,704Aug 09, 2022, 09:23 PM
Renger JohnChief Scientific OfficerAug 08, 2022 Sale$37.7510,000377,5002,704Aug 09, 2022, 09:23 PM
Renger JohnChief Scientific OfficerAug 05, 2022 Sale$32.5020,000650,0002,704Aug 09, 2022, 09:23 PM
Akamine ScottChief Legal OfficerAug 08, 2022 Option Exercise$13.1710,000131,70010,000Aug 09, 2022, 09:18 PM
Akamine ScottChief Legal OfficerAug 08, 2022 Sale$40.0010,000400,0010Aug 09, 2022, 09:18 PM
Ceesay AbrahamPresidentAug 08, 2022 Option Exercise$13.1719,211253,00919,211Aug 09, 2022, 08:59 PM
Ceesay AbrahamPresidentAug 05, 2022 Option Exercise$13.1738,424506,04438,424Aug 09, 2022, 08:59 PM
Ceesay AbrahamPresidentAug 08, 2022 Sale$38.6219,211742,0249,605Aug 09, 2022, 08:59 PM
Ceesay AbrahamPresidentAug 05, 2022 Sale$32.5038,4241,248,7800Aug 09, 2022, 08:59 PM
Renger JohnChief Scientific OfficerJul 20, 2022 Option Exercise$3.5025,00087,50027,704Jul 22, 2022, 04:15 PM
Renger JohnChief Scientific OfficerJul 20, 2022 Sale$30.0025,000750,0002,704Jul 22, 2022, 04:15 PM
Renger JohnChief Scientific OfficerJul 06, 2022 Option Exercise$3.501,1053,8683,809Jul 07, 2022, 04:06 PM
Renger JohnChief Scientific OfficerJul 05, 2022 Option Exercise$3.5025,00087,50027,704Jul 07, 2022, 04:06 PM
Renger JohnChief Scientific OfficerJul 06, 2022 Sale$32.501,10535,9132,704Jul 07, 2022, 04:06 PM
Renger JohnChief Scientific OfficerJul 05, 2022 Sale$30.0025,000750,0002,704Jul 07, 2022, 04:06 PM
Renger JohnChief Scientific OfficerApr 13, 2022 Option Exercise$3.5045,000157,50046,980Apr 15, 2022, 04:19 PM
Renger JohnChief Scientific OfficerApr 13, 2022 Sale$34.6545,0001,559,0921,980Apr 15, 2022, 04:19 PM
Renger JohnChief Scientific OfficerMar 29, 2022 Option Exercise$3.5010,00035,00011,980Mar 31, 2022, 04:05 PM
Renger JohnChief Scientific OfficerMar 29, 2022 Sale$35.0010,000350,0001,980Mar 31, 2022, 04:05 PM
Renger JohnChief Scientific OfficerMar 18, 2022 Option Exercise$3.5020,00070,00021,980Mar 18, 2022, 07:56 PM
Renger JohnChief Scientific OfficerMar 16, 2022 Option Exercise$3.5025,00087,50026,980Mar 18, 2022, 07:56 PM
Renger JohnChief Scientific OfficerMar 18, 2022 Sale$32.5020,000650,0041,980Mar 18, 2022, 07:56 PM
Renger JohnChief Scientific OfficerMar 16, 2022 Sale$30.0025,000750,0051,980Mar 18, 2022, 07:56 PM
Renger JohnChief Scientific OfficerMar 09, 2022 Option Exercise$3.5030,000105,00031,980Mar 11, 2022, 04:08 PM
Renger JohnChief Scientific OfficerMar 09, 2022 Sale$33.3330,0001,000,00011,980Mar 11, 2022, 04:08 PM
Renger JohnChief Scientific OfficerMar 02, 2022 Option Exercise$3.5025,00087,50026,980Mar 04, 2022, 04:12 PM
Renger JohnChief Scientific OfficerMar 02, 2022 Sale$30.0025,000750,0001,980Mar 04, 2022, 04:12 PM
Renger JohnChief Scientific OfficerFeb 09, 2022 Option Exercise$3.5025,00087,50026,980Feb 11, 2022, 06:46 PM
Renger JohnChief Scientific OfficerFeb 09, 2022 Sale$30.0025,000750,0001,980Feb 11, 2022, 06:46 PM
Renger JohnChief Scientific OfficerDec 27, 2021 Option Exercise$3.504,12714,4456,107Dec 28, 2021, 04:31 PM
Renger JohnChief Scientific OfficerDec 23, 2021 Option Exercise$3.505,87320,5567,853Dec 28, 2021, 04:31 PM
Renger JohnChief Scientific OfficerDec 23, 2021 Sale$35.005,873205,5821,980Dec 28, 2021, 04:31 PM
Renger JohnChief Scientific OfficerDec 27, 2021 Sale$35.004,127144,4451,980Dec 28, 2021, 04:31 PM
Renger JohnChief Scientific OfficerDec 21, 2021 Option Exercise$3.507,30025,5509,280Dec 23, 2021, 05:14 PM
Renger JohnChief Scientific OfficerDec 21, 2021 Sale$32.507,300237,2501,980Dec 23, 2021, 05:14 PM
Renger JohnChief Scientific OfficerDec 16, 2021 Option Exercise$3.505,57819,5237,558Dec 17, 2021, 08:27 PM
Renger JohnChief Scientific OfficerDec 15, 2021 Option Exercise$3.5025,00087,50026,980Dec 17, 2021, 08:27 PM
Renger JohnChief Scientific OfficerDec 17, 2021 Option Exercise$3.507,12224,9279,102Dec 17, 2021, 08:27 PM
Renger JohnChief Scientific OfficerDec 16, 2021 Sale$32.505,578181,2851,980Dec 17, 2021, 08:27 PM
Renger JohnChief Scientific OfficerDec 15, 2021 Sale$30.0225,000750,4481,980Dec 17, 2021, 08:27 PM
Renger JohnChief Scientific OfficerDec 17, 2021 Sale$32.507,122231,4651,980Dec 17, 2021, 08:27 PM
Renger JohnChief Scientific OfficerNov 10, 2021 Option Exercise$3.5055,000192,50055,000Nov 15, 2021, 04:18 PM
Renger JohnChief Scientific OfficerNov 10, 2021 Sale$39.8655,0002,192,18731,368Nov 15, 2021, 04:18 PM
PERCEPTIVE ADVISORS LLCDirectorAug 26, 2021 Buy$30.2368,0472,057,0615,086,727Aug 31, 2021, 02:15 PM
PERCEPTIVE ADVISORS LLCDirectorAug 25, 2021 Buy$28.5761,3871,753,8275,018,680Aug 25, 2021, 07:14 PM
PERCEPTIVE ADVISORS LLCDirectorAug 24, 2021 Buy$27.7369,7611,934,4724,957,293Aug 25, 2021, 07:14 PM
PERCEPTIVE ADVISORS LLCDirectorAug 23, 2021 Buy$25.7844,4371,145,5864,887,532Aug 25, 2021, 07:14 PM
PERCEPTIVE ADVISORS LLCDirectorJul 07, 2021 Buy$25.00200,0005,000,0004,843,095Jul 09, 2021, 06:39 PM
Sulzberger GabrielleDirectorJun 17, 2021 Buy$13.0621,084275,35735,354Jun 22, 2021, 06:31 PM
MISHAN ORLYChief Business OfficerJan 26, 2021 Option Exercise$3.5038,450134,57538,450Jan 28, 2021, 07:35 PM
BAIN CAPITAL INVESTORS LLC10% OwnerNov 09, 2020 Buy$10.30332,2933,422,61860,632,356Nov 12, 2020, 05:54 PM
Koppel AdamDirectorNov 09, 2020 Buy$10.30332,2933,422,61860,632,356Nov 12, 2020, 05:54 PM
Gordon Christopher RDirectorNov 09, 2020 Buy$10.30332,2933,422,61860,632,356Nov 12, 2020, 05:51 PM
PERCEPTIVE ADVISORS LLCDirectorOct 27, 2020 Buy$10.003,000,00030,000,0003,157,295Oct 29, 2020, 08:00 PM
Koppel AdamDirectorOct 27, 2020 Buy$10.0010,000,000100,000,00060,300,063Oct 29, 2020, 08:00 PM
BAIN CAPITAL INVESTORS LLC10% OwnerOct 27, 2020 Buy$10.0010,000,000100,000,00060,300,063Oct 29, 2020, 08:00 PM
Gordon Christopher RDirectorOct 27, 2020 Buy$10.0010,000,000100,000,00060,300,063Oct 29, 2020, 08:00 PM
PFIZER INC10% OwnerOct 27, 2020 Buy$10.001,200,00012,000,00027,349,211Oct 29, 2020, 05:44 PM
PERCEPTIVE ADVISORS LLCDirectorOct 21, 2020 Buy$10.0943,195435,838157,295Oct 22, 2020, 08:34 PM
PERCEPTIVE ADVISORS LLCDirectorOct 20, 2020 Buy$10.00114,1001,141,000114,100Oct 22, 2020, 08:34 PM
ARYA Sciences Holdings II10% OwnerJun 09, 2020 Option Exercise$10.00499,0004,990,000499,000Jun 09, 2020, 08:25 PM
Stone Adam LeoChief Executive OfficerJun 09, 2020 Option Exercise$10.00499,0004,990,000499,000Jun 09, 2020, 08:25 PM
ALTMAN MICHAEL SETHChief Financial OfficerJun 09, 2020 Option Exercise$10.00499,0004,990,000499,000Jun 09, 2020, 08:23 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
COLES N ANTHONYDirector04/01/2024175,000
COLES N ANTHONYDirector04/01/20242,116,640
COLES N ANTHONYDirector03/04/2024175,000
COLES N ANTHONYDirector03/04/20242,050,550
COLES N ANTHONYDirector02/29/2024175,000
COLES N ANTHONYDirector02/29/20242,057,890
Renger JohnChief Scientific Officer02/07/202489,777
COLES N ANTHONYDirector02/07/2024104,110
Tregoning KathleenSee Remarks12/26/202331,658
Sanchez RamiroChief Medical Officer12/26/202335,000
Sanchez RamiroChief Medical Officer12/26/2023424,700
DiPietro KennethChief Human Resources Officer12/22/202328,000
DiPietro KennethChief Human Resources Officer12/22/2023331,608
Bodenrader MarkSee Remarks12/20/2023326,788
DiPietro KennethChief Human Resources Officer12/20/2023259,144
Akamine ScottChief Legal Officer12/20/2023292,945
Sanchez RamiroChief Medical Officer12/20/2023420,528
ALTSCHULLER SusanChief Financial Officer12/20/2023571,972
Tregoning KathleenSee Remarks12/20/2023260,469
Sanchez RamiroChief Medical Officer12/15/202374,100
Sanchez RamiroChief Medical Officer12/15/2023310,393
Sanchez RamiroChief Medical Officer12/07/202335,000
Sanchez RamiroChief Medical Officer12/07/2023413,700
Akamine ScottChief Legal Officer12/07/2023131,700
Akamine ScottChief Legal Officer12/05/202398,775
Akamine ScottChief Legal Officer12/07/2023413,700
Akamine ScottChief Legal Officer12/05/2023262,500
COLES N ANTHONYDirector11/14/202379,884
COLES N ANTHONYDirector11/14/2023573,455
COLES N ANTHONYDirector11/08/2023350
COLES N ANTHONYDirector11/07/202394,766
COLES N ANTHONYDirector11/08/20232,516
COLES N ANTHONYDirector11/07/2023677,555
COLES N ANTHONYDirector11/02/2023135,097
COLES N ANTHONYDirector11/03/2023214,904
COLES N ANTHONYDirector11/03/20231,561,458
COLES N ANTHONYDirector11/02/2023972,239
PATRICK DEVAL LDirector11/01/2023380,241
PATRICK DEVAL LDirector11/01/2023753,250
Gordon Christopher RDirector10/16/2023124,999,983
Koppel AdamDirector10/16/2023124,999,983
BAIN CAPITAL INVESTORS LLC10% Owner10/16/2023124,999,983
PERCEPTIVE ADVISORS LLCDirector10/16/202319,999,990
COLES N ANTHONYDirector09/07/2023175,000
COLES N ANTHONYDirector09/07/20231,203,415
Renaud Ronald C JRPresident & CEO08/03/20232,008,811
Burgess Paul D.See Remarks08/04/2023501,794
COLES N ANTHONYDirector07/11/2023175,000
COLES N ANTHONYDirector07/11/20231,501,340
DEKKERS MARIJN EDirector06/15/20236,886,000
COLES N ANTHONYCEO and Chairperson06/01/2023175,000
COLES N ANTHONYCEO and Chairperson06/01/20231,630,070
Bodenrader MarkSee Remarks06/02/202362,440
COLES N ANTHONYCEO and Chairperson05/04/2023175,000
COLES N ANTHONYCEO and Chairperson05/04/20231,573,434
COLES N ANTHONYCEO and Chairperson04/11/2023175,000
COLES N ANTHONYCEO and Chairperson04/11/20231,253,130
COLES N ANTHONYCEO and Chairperson03/03/202310,500
COLES N ANTHONYCEO and Chairperson03/02/2023164,500
COLES N ANTHONYCEO and Chairperson03/03/202381,570
COLES N ANTHONYCEO and Chairperson03/02/20231,274,377
COLES N ANTHONYCEO and Chairperson02/07/2023175,000
COLES N ANTHONYCEO and Chairperson02/07/20231,656,401
COLES N ANTHONYCEO and Chairperson01/05/2023175,000
COLES N ANTHONYCEO and Chairperson01/05/20231,496,871
COLES N ANTHONYCEO and Chairperson12/09/2022175,000
COLES N ANTHONYCEO and Chairperson12/09/20221,333,300
Renger JohnChief Scientific Officer11/01/2022189,078
Renger JohnChief Scientific Officer11/01/2022750,005
Renger JohnChief Scientific Officer10/04/2022189,078
Renger JohnChief Scientific Officer10/04/2022750,000
PATRICK DEVAL LDirector09/12/2022602,037
PATRICK DEVAL LDirector09/12/20221,468,422
Ceesay AbrahamPresident09/08/2022252,996
Ceesay AbrahamPresident09/08/2022624,325
Ceesay AbrahamPresident08/22/2022126,498
Ceesay AbrahamPresident08/22/2022312,163
PERCEPTIVE ADVISORS LLCDirector08/16/202249,875,000
Ceesay AbrahamPresident08/15/2022126,511
Ceesay AbrahamPresident08/15/2022327,757
Renger JohnChief Scientific Officer08/10/2022364,549
Renger JohnChief Scientific Officer08/10/20222,227,624
Renger JohnChief Scientific Officer08/08/202235,000
Renger JohnChief Scientific Officer08/05/202270,000
Renger JohnChief Scientific Officer08/08/2022377,500
Renger JohnChief Scientific Officer08/05/2022650,000
Akamine ScottChief Legal Officer08/08/2022131,700
Akamine ScottChief Legal Officer08/08/2022400,001
Ceesay AbrahamPresident08/08/2022253,009
Ceesay AbrahamPresident08/05/2022506,044
Ceesay AbrahamPresident08/08/2022742,024
Ceesay AbrahamPresident08/05/20221,248,780
Renger JohnChief Scientific Officer07/20/202287,500
Renger JohnChief Scientific Officer07/20/2022750,000
Renger JohnChief Scientific Officer07/06/20223,868
Renger JohnChief Scientific Officer07/05/202287,500
Renger JohnChief Scientific Officer07/06/202235,913
Renger JohnChief Scientific Officer07/05/2022750,000
Renger JohnChief Scientific Officer04/13/2022157,500
Renger JohnChief Scientific Officer04/13/20221,559,092
Renger JohnChief Scientific Officer03/29/202235,000
Renger JohnChief Scientific Officer03/29/2022350,000
Renger JohnChief Scientific Officer03/18/202270,000
Renger JohnChief Scientific Officer03/16/202287,500
Renger JohnChief Scientific Officer03/18/2022650,004
Renger JohnChief Scientific Officer03/16/2022750,005
Renger JohnChief Scientific Officer03/09/2022105,000
Renger JohnChief Scientific Officer03/09/20221,000,000
Renger JohnChief Scientific Officer03/02/202287,500
Renger JohnChief Scientific Officer03/02/2022750,000
Renger JohnChief Scientific Officer02/09/202287,500
Renger JohnChief Scientific Officer02/09/2022750,000
Renger JohnChief Scientific Officer12/27/202114,445
Renger JohnChief Scientific Officer12/23/202120,556
Renger JohnChief Scientific Officer12/23/2021205,582
Renger JohnChief Scientific Officer12/27/2021144,445
Renger JohnChief Scientific Officer12/21/202125,550
Renger JohnChief Scientific Officer12/21/2021237,250
Renger JohnChief Scientific Officer12/16/202119,523
Renger JohnChief Scientific Officer12/15/202187,500
Renger JohnChief Scientific Officer12/17/202124,927
Renger JohnChief Scientific Officer12/16/2021181,285
Renger JohnChief Scientific Officer12/15/2021750,448
Renger JohnChief Scientific Officer12/17/2021231,465
Renger JohnChief Scientific Officer11/10/2021192,500
Renger JohnChief Scientific Officer11/10/20212,192,187
PERCEPTIVE ADVISORS LLCDirector08/26/20212,057,061
PERCEPTIVE ADVISORS LLCDirector08/25/20211,753,827
PERCEPTIVE ADVISORS LLCDirector08/24/20211,934,472
PERCEPTIVE ADVISORS LLCDirector08/23/20211,145,586
PERCEPTIVE ADVISORS LLCDirector07/07/20215,000,000
Sulzberger GabrielleDirector06/17/2021275,357
MISHAN ORLYChief Business Officer01/26/2021134,575
BAIN CAPITAL INVESTORS LLC10% Owner11/09/20203,422,618
Koppel AdamDirector11/09/20203,422,618
Gordon Christopher RDirector11/09/20203,422,618
PERCEPTIVE ADVISORS LLCDirector10/27/202030,000,000
Koppel AdamDirector10/27/2020100,000,000
BAIN CAPITAL INVESTORS LLC10% Owner10/27/2020100,000,000
Gordon Christopher RDirector10/27/2020100,000,000
PFIZER INC10% Owner10/27/202012,000,000
PERCEPTIVE ADVISORS LLCDirector10/21/2020435,838
PERCEPTIVE ADVISORS LLCDirector10/20/20201,141,000
ARYA Sciences Holdings II10% Owner06/09/20204,990,000
Stone Adam LeoChief Executive Officer06/09/20204,990,000
ALTMAN MICHAEL SETHChief Financial Officer06/09/20204,990,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CEREVEL THERAPEUTICS HOLDINGS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.6,027,5250.00652%20.77%Other
BALYASNY ASSET MANAGEMENT L.P.1,941,2150.15%6415.02%Event Driven
GEODE CAPITAL MANAGEMENT, LLC1,789,3020.00794%24.32%Other
BAKER BROS. ADVISORS LP1,600,0000.77%NewOther
PENTWATER CAPITAL MANAGEMENT LP1,100,0000.52%NewEvent Driven
MAGNETAR FINANCIAL LLC1,018,4281.1%NewEvent Driven, Other
AQR ARBITRAGE LLC933,7641.6%NewEvent Driven
WESTCHESTER CAPITAL MANAGEMENT, LLC729,3101.08%NewEvent Driven
ADAGE CAPITAL PARTNERS GP, L.L.C.619,2060.05%-58.88%Other
WATER ISLAND CAPITAL LLC588,1002.55%NewEvent Driven
FARALLON CAPITAL MANAGEMENT LLC567,3210.12%NewEvent Driven, Value
GABELLI FUNDS LLC465,6210.15%NewEvent Driven, Growth, Activists
MELQART ASSET MANAGEMENT (UK) LTD286,3930.89%NewEvent Driven
RENAISSANCE TECHNOLOGIES LLC239,5000.02%NewOther
TWIN SECURITIES, INC.232,70510.41%NewEvent Driven
BALYASNY ASSET MANAGEMENT L.P.225,000 (Call)0.02%NewEvent Driven
WESTCHESTER CAPITAL MANAGEMENT, LLC200,000 (Put)0.3%NewEvent Driven
CANDRIAM S.C.A.167,2210.05%-48.9%Other
ALPS ADVISORS INC97,6890.03%-15.98%Other
BALYASNY ASSET MANAGEMENT L.P.62,100 (Put)0.00494%NewEvent Driven
KELLNER CAPITAL, LLC20,3001.55%NewEvent Driven
AQR CAPITAL MANAGEMENT LLC19,5780.00156%NewOther
BLACKSTONE INC.14,5450.00277%NewOther
GOTHAM ASSET MANAGEMENT, LLC9,3940.00739%NewOther
CHANGE IN SHARES OUTSTANDING FOR CEREVEL THERAPEUTICS HOLDINGS INC
STOCK BUYBACKS FOR CEREVEL THERAPEUTICS HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
12.39%
1Q
12/31/2023
06/30/2023
12.71%
2Q
12/31/2023
03/31/2023
13.00%
3Q
12/31/2023
12/31/2022
13.16%
4Q
12/31/2023
09/30/2022
16.23%
5Q
12/31/2023
06/30/2022
19.37%
6Q
12/31/2023
03/31/2022
19.62%
7Q
12/31/2023
12/31/2021
20.10%
8Q
12/31/2023
09/30/2021
22.91%
9Q
12/31/2023
06/30/2021
38.86%
10Q
12/31/2023
03/31/2021
39.14%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
12.39%
1Q
06/30/2023
12.71%
2Q
03/31/2023
13.00%
3Q
12/31/2022
13.16%
4Q
09/30/2022
16.23%
5Q
06/30/2022
19.37%
6Q
03/31/2022
19.62%
7Q
12/31/2021
20.10%
8Q
09/30/2021
22.91%
9Q
06/30/2021
38.86%
10Q
03/31/2021
39.14%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CEREVEL THERAPEUTICS HOLDINGS INC
LOADING...